Asian Penny Stocks To Watch In September 2026

The Asian markets are currently navigating a complex landscape marked by geopolitical tensions and fluctuating oil prices, which have led to inflationary pressures and shifts in monetary policy expectations. Amidst these challenges, investors are increasingly looking for opportunities that can offer growth potential while managing risk. Though the term 'penny stock' might sound like a relic of past trading days, the opportunity it points to is still relevant. These smaller or newer companies, when built on solid financials, can lead to significant returns.

Here we highlight a subset of our preferred stocks from the screener.

Gentrack Group (NZSE:GTK)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Gentrack Group Limited develops, integrates, and supports enterprise billing and customer management software solutions for the energy, water utility, and airport industries with a market cap of NZ$466.70 million.

Operations: The company generates revenue from two main segments: Utility, contributing NZ$191.00 million, and Airport, with NZ$37.34 million.

Market Cap: NZ$466.7M

Gentrack Group has shown promising financial performance, with current net profit margins improving to 8.2% from last year's 5.1%, and earnings growth of 64.9% over the past year surpassing the software industry average. The company is debt-free, which strengthens its financial position, and it has not diluted shareholders recently. However, Gentrack's share price remains highly volatile. Recent board changes include the retirement of long-standing directors and the appointment of experienced new members like Stewart Taylor and Laurence Lafont, potentially bringing fresh perspectives to governance amid ongoing strategic initiatives in enterprise software solutions.

• Jump into the full analysis health report here for a deeper understanding of Gentrack Group.
• Assess Gentrack Group's future earnings estimates with our detailed growth reports.

EverChina Int'l Holdings (SEHK:202)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: EverChina Int'l Holdings Company Limited is an investment holding company involved in property investment and hotel operations in China and Bolivia, with a market cap of HK$452.25 million.

Operations: The company's revenue is primarily derived from its agricultural operations, generating HK$96.40 million, and property investment operations, contributing HK$30.93 million.

Market Cap: HK$452.25M

EverChina Int'l Holdings faces financial challenges, with a net loss of HK$67.01 million for the year ending March 2026 and doubts about its ability to continue as a going concern. The company's short-term assets of HK$167.4 million do not cover its short-term liabilities of HK$317 million, though they exceed long-term liabilities of HK$29.8 million. Despite reducing debt over five years and maintaining a satisfactory net debt to equity ratio of 21.1%, the company remains unprofitable with negative return on equity (-6.85%). Its share price is highly volatile, and it has less than one year of cash runway if cash flow trends persist.

• Unlock comprehensive insights into our analysis of EverChina Int'l Holdings stock in this financial health report.
• Evaluate EverChina Int'l Holdings' historical performance by accessing our past performance report.

IFBH (SEHK:6603)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: IFBH Limited operates in the production of fruit juice-based beverages and non-beverage fruit products, with a market capitalization of approximately HK$1.12 billion.

Operations: The company generates revenue of $132.33 million from its beverage and snack sales segment.

Market Cap: HK$1.12B

IFBH Limited, with a market cap of HK$1.12 billion, recently reported a significant decline in earnings for the first half of 2026 due to global supply chain disruptions affecting key materials like PET and coconut water. This led to reduced sales of US$50.4 million compared to US$94.46 million the previous year, impacting net income and profit margins negatively. Despite these challenges, IFBH remains debt-free with strong short-term assets exceeding liabilities by a large margin and is trading significantly below its estimated fair value, presenting potential opportunities if supply issues resolve and management stabilizes operations.

• Dive into the specifics of IFBH here with our thorough balance sheet health report.
• Learn about IFBH's future growth trajectory here.

Taking Advantage

• Investigate our full lineup of 1,052 Asian Penny Stocks right here.
• Interested In Other Possibilities? The end of cancer? These 35 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com